Omnicell acquires MarkeTouch Media for $82M

Omnicell acquires MarkeTouch Media for $82M
Omnicell completes $100M acquisition of ReCept
Hill-Rom jumps after report of Baxter takeover offer; Omnicell shares fall
Omnicell to acquire FDS Amplicare for $177M
1.96BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US68213N1090
CUSIP
68213N109
Sector
Healthcare
Industry
Health Information Services
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
98.57
PEG Ratio
15.40
Book Value
27.63
Dividend Share
-
Dividend Yield
-
Earnings Share
0.42
Wall Street Target Price
61.29
EPS Estimate Current Year
1.94
EPS Estimate Next Year
2.20
EPS Estimate Current Quarter
0.3313
EPS Estimate Next Quarter
0.4163
Most Recent Quarter
-
Revenue TTM
1,225,057,024
Gross Profit TTM
537,470,016
EBITDA
73,610,000
Profit Margin
1.67%
Return On Assets TTM
1.21%
Return On Equity TTM
1.63%
Revenue Per Share TTM
26.838
Qtly Revenue Growth YOY
14.90%
Diluted Eps TTM
0.42
Qtly Earnings Growth YOY
-35.90%
Trailing PE
98.57
Forward PE
29
Price Sales TTM
1.5369
Price Book MRQ
1.4987
Enterprise Value Revenue
1
Enterprise Value EBITDA
15
203.19
0.55%21.11
0.26%0.97
0.00%112.23
0.00%59.68
-18.13%5.52
-6.76%46.54
-5.87%43.78
-1.37%74.71
-0.65%100.62
-0.39%